Childhood Cancer News

Home » Childhood Cancer News

High-risk neuroblastoma in children has a grim outlook. Dr. Jonus is fighting to change that.

Neuroblastoma is the most common extracranial solid tumor of childhood arising within the developing nervous system. Approximately half of neuroblastoma patients are diagnosed with high-risk disease, which is especially aggressive with a 50% survival rate. If a child’s high-risk neuroblastoma […]

High-risk neuroblastoma in children has a grim outlook. Dr. Jonus is fighting to change that. Read More »

Dr. Hunter Jonus

From Bench to Bedside in 18 Months: How collaboration landed adolescent-young adult (AYA) patients in a clinical trial

“We were fortunate that CureSearch had just launched their Catapult Award program….It enabled researchers to access up to $2.5M in funding over three years, through a streamlined application process, rather than contending with multiple applications for smaller grants which would have lengthened

From Bench to Bedside in 18 Months: How collaboration landed adolescent-young adult (AYA) patients in a clinical trial Read More »

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within

As we work to find new and less-toxic treatments for pediatric cancers, we know that smarter research funding is just one part of the solution. Long-term solutions require a seismic shift in the existing pediatric drug development process. This change

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within Read More »

Volunteer Week 2020

COVID-19 Impact and Action

Updated 5/1/20 To the CureSearch Community: Like you, we’re closely monitoring the evolving situation surrounding COVID-19. With the safety of our patient families, volunteers and staff top of mind, all CureSearch-sponsored events through June 1st have been postponed, including our

COVID-19 Impact and Action Read More »

Coronavirus COVID-19

Children are waiting longer than adults to access new cancer drugs. CureSearch is changing that.

CureSearch IMPACT Series Forums bring global pediatric experts in academia and pharmaceutical companies together to accelerate the development of pediatric cancer drugs. “Children with cancer wait an average of 6.5 years longer than adults to access new drugs.”1 Cancer is

Children are waiting longer than adults to access new cancer drugs. CureSearch is changing that. Read More »

New Therapies for Pediatric Oncology

CureSearch for Children’s Cancer Announces Research Award Opportunities in 2019

Media Contact: Caitlyn Barrett National Director, Research and Programs Phone: (240) 235-2215 | caitlyn.barrett@curesearch.org CureSearch for Children’s Cancer AnnouncesResearch Award Opportunities Up to $5 million in research awards will accelerate the development of better, less-toxic children’s cancer treatments Bethesda, MD

CureSearch for Children’s Cancer Announces Research Award Opportunities in 2019 Read More »

CureSearch for Children's Cancer

Pin It on Pinterest

Scroll to Top